快速单抗平台,提供各类靶标的单克隆抗体,包括IL-3、IL-6、IFN-γ、GM-CSF、TNF-α及CD系列鼠单克隆流式抗体。
Item | Cat. No. | Species | Species Reactivity | Type | Application |
Anti-Spike protein (RBD) mabs [Sb#45](MABL-3558) | MABL-3558 | Engineer | SARSCoronavirus2 (SARS-Cov-2) | Recombinate | grating-coupledinterferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) mabs [Sb#42](MABL-3557) | MABL-3557 | Engineer | SARSCoronavirus2 (SARS-Cov-2) | Recombinate | grating-coupledinterferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) mabs [Sb#16](MABL-3556) | MABL-3556 | Engineer | SARSCoronavirus2 (SARS-Cov-2) | Recombinate | grating-coupledinterferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) mabs [Sb#15](MABL-3555) | MABL-3555 | Engineer | SARSCoronavirus2 (SARS-Cov-2) | Recombinate | grating-coupledinterferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) mabs [Sb#14]](MABL-3554) | MABL-3554 | Engineer | SARSCoronavirus2 (SARS-Cov-2) | Recombinate | grating-coupledinterferometry, inhibition, therapeutics, ELISA |
Anti-Covid-19 & SARS-CoV Nucleoprotein mabs [CR3009 (03-009)](MABL-3553) | MABL-3553 | Engineer | SARS-CoV, SARS-CoV2 | Recombinate | ELISA, IF |
Anti-Covid-19 & SARS-CoV Nucleoprotein mabs [CR3018 (03-018)](MABL-3552) | MABL-3552 | Engineer | SARS-CoV, SARS-CoV2 | Recombinate | ELISA, IF |
Anti-COVID-19 & SARS-CoV S glycoprotein mabs [CR3022](MABL-3551) | MABL-3551 | Engineer | SARS-CoV-2 (COVID-19)&SARSCoronavirus | Recombinate | crystallography, NTRL, SPR, ELISA, IF |
Anti-Spike Protein (RBD) [CV30](MABL-3550) | MABL-3550 | Engineer | SARSCoronavirus2 | Recombinate | neutralize, therapeutic, ELISA, FC |
Anti-Spike Protein [CV1](MABL-3549) | MABL-3549 | Engineer | SARSCoronavirus2 | Recombinate | neutralize ,therapeutic, ELISA, FC |
Anti-Ebola Nucleoprotein mAbs [KZ51](MABL-3548) | MABL-3548 | Engineer | EbolaVirus (Zaire, IvoryCoast, Reston, Sudan) | Recombinate | IP, WB, ELISA, IF |
Anti-Ebola surface glycoprotein mAbs [KZ52](MABL-3547) | MABL-3547 | Engineer | Ebola (Zaire) | Recombinate | crystallization, IP, NTRL, IF |
Anti-GM-CSF mAbs [GCC21](MABL-3546) | MABL-3546 | Engineer | Human | Recombinate | Biacore, NTRL, ELISA |
Anti-GM-CSF mAbs [GCA43](MABL-3545) | MABL-3545 | Engineer | Human | Recombinate | Biacore, NTRL, ELISA |
Anti-HIV-1 GP120 mAbs [HR12](MABL-3544) | MABL-3544 | Engineer | HIV-1 | Recombinate | NTRL |
Anti-HIV-1 GP120 mAbs [HR10](MABL-3543) | MABL-3543 | Engineer | HIV-1 | Recombinate | NTRL |
Anti-HIV-1 GP41 mAbs [HK20](MABL-3542) | MABL-3542 | Engineer | HIV-1 | Recombinate | NTRL |
Anti-HIV-1 GP120 mAbs [HJ16](MABL-3541) | MABL-3541 | Engineer | HIV-1 | Recombinate | NTRL |
Anti-HIV-1 GP120 mAbs [HGZ1](MABL-3540) | MABL-3540 | Engineer | HIV-1 | Recombinate | NTRL |
Anti-HIV-1 GP120 mAbs [HGN194](MABL-3539) | MABL-3539 | Engineer | HIV-1 | Recombinate | NTRL |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn